Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × CD2-associated protein × 30 days × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 93 Specimen Handling 86 Cyclophosphamide 83 pembrolizumab 82 Radiotherapy 71 Biopsy 62 venetoclax 59 Nivolumab 51 Cisplatin 44 Carboplatin 44 Radiosurgery 41 Dexamethasone 41 fludarabine 40 Drug Therapy 37 Blood Specimen Collection 37 Standard of Care 35 Azacitidine 35 Rituximab 34 Paclitaxel 34 Surveys and Questionnaires 32 Oxaliplatin 32 Bevacizumab 32 Gemcitabine 30 Cytarabine 30 X-Rays 28 Ipilimumab 28 Radiation 27 durvalumab 26 fludarabine phosphate 25 Fluorouracil 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07478016 2026-03-17

EXIST

Thomas Jefferson University

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡